Cardinal Health(US:CAH) ZACKS·2025-11-24 15:15Core Insights - Cardinal Health (CAH) shares have increased by 29.4% over the past month, reaching a new 52-week high of $210.33, and have gained 77.1% since the start of the year, outperforming the Zacks Medical sector and the Zacks Medical - Dental Supplies industry [1] Financial Performance - Cardinal Health has consistently beaten earnings estimates, reporting EPS of $2.55 against a consensus estimate of $2.21 in its last earnings report on October 30, 2025, and exceeding revenue estimates by 8.39% [2] - For the current fiscal year, Cardinal is projected to achieve earnings of $9.86 per share on revenues of $258.58 billion, reflecting a 19.66% increase in EPS and a 16.18% increase in revenues. For the next fiscal year, earnings are expected to rise to $10.9 per share on revenues of $277.02 billion, indicating year-over-year changes of 10.53% and 7.13%, respectively [3] Valuation Metrics - Cardinal Health has a Value Score of A, a Growth Score of A, and a Momentum Score of C, resulting in a combined VGM Score of A, indicating strong potential for value investors [6] - The stock trades at 21.3 times current fiscal year EPS estimates, above the peer industry average of 15 times, and at 18 times trailing cash flow compared to a peer average of 12 times. The PEG ratio stands at 1.52, placing Cardinal in the top tier of stocks from a value perspective [7] Zacks Rank - Cardinal Health holds a Zacks Rank of 2 (Buy), supported by rising earnings estimates, making it a suitable choice for investors looking for stocks with strong potential [8] Industry Comparison - The Medical - Dental Supplies industry is performing well, ranking in the top 22% of all industries, providing favorable conditions for both Cardinal Health and its peer, McKesson Corporation (MCK), which also has a Zacks Rank of 2 (Buy) [11]